Clinical trials in Vila Nova De Gaia – page 32

680 clinical trials in Vila Nova De Gaia, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.

Our site in PortugalEnsaios-Clinicos.pt

Vila Nova De Gaia at a glance

680

clinical trials

Research sites0

Quick filters

680 trials in Vila Nova De Gaia

Open in trial search

Aplastic anaemia+1

Not recruiting

A study to compare the absorption of eltrombopag olamine in healthy volunteers to ensure the tablets work the same way for patients with thrombocytopenia or aplastic anemia.

Registered drugNo placebo

A study to compare the absorption of eltrombopag olamine in healthy volunteers to ensure the tablets work the same way for patients with thrombocytopenia or aplastic anemia.

Registered drugNo placebo

Portugal

Participants:18–64 years · Healthy volunteers
Substances:Eltrombopag olamine
Sponsor:Bluepharma Industria Farmaceutica S.A.

Contact Research Centre

Hypogonadism male

Not recruiting

A study to compare the absorption of testosterone transdermal gel in healthy female subjects

Registered drugNo placebo

A study to compare the absorption of testosterone transdermal gel in healthy female subjects

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Testosterone
Sponsor:Laboratorios Leon Farma S.A.

Contact Research Centre

Nicotine dependence

Not recruiting

A study to evaluate how cytisinicline works in patients with nicotine addiction and kidney problems or those undergoing dialysis

InvestigationalNo placebo

A study to evaluate how cytisinicline works in patients with nicotine addiction and kidney problems or those undergoing dialysis

InvestigationalNo placebo

Portugal

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Cytisinicline
Sponsor:Achieve Life Sciences Inc.

Contact Research Centre

Angelman's syndrome

Not recruiting

A Study Testing the Safety and How Well GTX-102 Works in Adults and Children with Angelman Syndrome

InvestigationalNo placebo

A Study Testing the Safety and How Well GTX-102 Works in Adults and Children with Angelman Syndrome

InvestigationalNo placebo

Portugal

Participants:0–17 years · 18–64 years
Substances:Apazunersen
Sponsor:Ultragenyx Pharmaceutical Inc.

Contact Research Centre

Pneumonia+1

Not recruiting

A study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia

Investigational

A study testing trimodulin in hospitalized adult patients with community-acquired pneumonia including COVID-19 pneumonia

Investigational

Portugal

Participants:18–64 years · 65+ years
Sponsor:Biotest GmbH & Co. KGaA

Contact Research Centre

Breast cancer+3

Not recruiting

Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

Registered drug

Study of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Romiplostim
Sponsor:Amgen Inc.

Contact Research Centre

Aplastic anaemia+1

Not recruiting

A Study Comparing Eltrombopag Tablets in Healthy Volunteers to Test if Two Forms of the Medicine Work the Same Way in the Body After Taking with Food

Registered drugNo placebo

A Study Comparing Eltrombopag Tablets in Healthy Volunteers to Test if Two Forms of the Medicine Work the Same Way in the Body After Taking with Food

Registered drugNo placebo

Portugal

Participants:18–64 years · Healthy volunteers
Substances:Eltrombopag olamine
Sponsor:Bluepharma Industria Farmaceutica S.A.

Contact Research Centre

Endometrial cancer+2

Not recruiting

A study comparing how lenvatinib capsules are absorbed in the body in healthy volunteers under fasting and fed conditions

Registered drugNo placebo

A study comparing how lenvatinib capsules are absorbed in the body in healthy volunteers under fasting and fed conditions

Registered drugNo placebo

Portugal

Participants:18–64 years · Healthy volunteers
Substances:Lenvatinib
Sponsor:Bluepharma Industria Farmaceutica S.A.

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Salbutamol
Sponsor:AstraZeneca AB

Contact Research Centre

Dermatomyositis

Not recruiting

A study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe

Investigational

A study testing brepocitinib compared to placebo for adults with dermatomyositis to see if it works and is safe

Investigational

Portugal

Participants:18–64 years · 65+ years
Sponsor:Priovant Therapeutics Inc.

Contact Research Centre

Chronic obstructive pulmonary disease

Not recruiting

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug

Study of Tozorakimab for Patients with Chronic Obstructive Pulmonary Disease Who Have Symptoms and a History of Flare-ups

Registered drug

Portugal

Participants:18–64 years · 65+ years
Substances:Salbutamol Sulfate
Sponsor:AstraZeneca AB

Contact Research Centre

Neovascular age-related macular degeneration

Not recruiting

A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration

Registered drugNo placebo

A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration

Registered drugNo placebo

Portugal

Participants:18–64 years · 65+ years
Substances:Aflibercept
Sponsor:4d Molecular Therapeutics Inc.

Contact Research Centre

Other cities in Portugal

The busiest research cities in the country

All 47 cities in Portugal

Clinical research in Vila Nova De Gaia

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on head and neck cancer, breast cancer, and multiple myeloma treatments. Studies include evaluations of novel therapies for both early-stage and metastatic conditions.

Advanced Head & Neck Squamous Cell Carcinoma
HER2-positive Breast Cancer
Multiple Myeloma Maintenance Therapy

Research encompasses targeted therapies and combination treatments aimed at improving patient outcomes.

02 Autoimmune Disorders

Comprehensive studies investigating treatments for various autoimmune conditions, including Sjögren's Syndrome and systemic sclerosis. Focus on developing targeted therapies for immune system regulation.

Primary Sjögren's Disease
Diffuse Cutaneous Systemic Sclerosis
Immune Thrombocytopenia

Evaluating novel biological therapies to address complex autoimmune manifestations.

03 Metabolic & Cardiovascular Studies

Research focused on obesity management and cardiovascular health. Studies evaluate new therapeutic approaches for weight management and cardiovascular disease prevention.

Obesity Treatment
Pulmonary Arterial Hypertension
Cardiovascular Risk Management

Investigating innovative treatments to address growing metabolic health challenges.

Back to Portugal All countries